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From Gender to Genomics: Achievements and
Challenges in Sex-Specific Science*
Marianne J. Legato, MD**
What I would like to talk about today is an overview, of sorts, of what I
have gleaned in my long saga of trying to understand about the differences
between the sexes, at all levels, and whether or not they are important to us
who are practicing physicians. As heard as a subtext today, scientific
research and medical practice come from the societies in which they are
imbedded. We do not spring antiseptically prepared and fully formed as
objective characters from the brow of Zeus. We reflect our own history,
our own perceptions, and it is not surprising that as Heraclitus said,
"Nothing is constant but change." And we change opinions and views as
the society around us does.
The past two decades have been really interesting, because of the
profundity of the change and how we approach biomedical investigation in
terms of whom we look at and what we are looking for. We have what
could really be called a radically new view of normal biology and the
pathophysiology of disease. I was thinking this morning, listening to the
experts on coronary disease, that the impact of estrogen on nitrous oxide in
the endothelium of women was not even mentioned and so, our knowledge
far exceeds the time that we are given to talk, but there are some very
interesting dilemmas and little byways in the differences in the
pathogenesis of coronary disease between the sexes that are fascinating and
here is why.
Up until the 1980s, we had what I called the bikini view of medicine.
Men were considered normative for the whole population, and
paradoxically I think we have exploited men and not really considered the
things that are unique to them in terms of vulnerability and their needs. My
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last book is called Why Men Die First. And although the title is somewhat
prohibitive-men don't pick it up in my office-it is a very interesting
treatise on the fact that while we have done all of our biological or
biomedical research on males for very interesting reasons, most of them
very practical, we have not really considered their unique needs.
The other eternal question, which was formed as we began to study
women and noticed the variety and extent of the differences between men
and women in all the systems of the body, is what about a man or a woman
is hard-wired in terms of the biology, inescapable and immutable, and
which are the consequences of training, social forces, and the environment?
We will never really get the answers to that question but it is the question
that I think should be in all of our minds as we look at the differences
between the sexes.
Progress and medicine, like everything, is embedded in history and I
want to show you what I think the elements were and how women came to
insist upon and receive attention from the biomedical community.
First, women in 1900 had very little control over the world around
them and their best bet for power over the environment was marriage or an
alliance with a powerful man. The average life expectancy was forty-eight
for both sexes, so the whole question of menopause and aging only arose
almost peripherally. Finally, the third ingredient in the last century was that
the physician had very little power over disease in terms of cure or
prevention. His best efforts were-and this can be seen in any text from
that time-in the brilliant description of disease and its course. He was a
great prophet of what would happen to the patient he was observing and so
he was invested with sort of magical powers and a seeing eye that none of
the rest of the public had. That was the situation.
World War II, and a little bit less impressively World War I, was
tremendously significant in the history of why we are now so interested in
women. First of all, men were away long enough, and in enough numbers,
so that women had to fulfill roles that they had never filled before. Dr.
Irene Ferrer was appointed the first Chief Resident of Medicine at
Columbia University at the Bellevue site, simply because there were no
men to take that place. The second thing is that the exigencies of the war
forced scientists and particularly physicians to develop capacities they
never before had the need to develop. For example, the whole discipline of
plastic surgery began on the battle fields of World War I when John
Converse, as a twenty-three-year-old surgeon with one year of training saw
the ravages of the wounds that the French army was experiencing and he
began to develop what was a rather well-developed system of plastic repair.
Finally, you might like to know that the third-party payer came into
existence for the first time during World War II. A historical idea, because
wages and prices were frozen, the Kaiser shipping company decided that it
would give health care plans to its employees and it was used to develop
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the notion that a corporation, and by analogy, a government, was
responsible for the health of its people. It was a revolutionary concept at
the time.
So these were the huge changes of World War II. And the rise of
feminism that was inevitable after World War II, when women would not
go back to the kitchens and other kinds of domestic pursuits, but had a
sense of their competence and their ability to make decisions that they did
not relinquish. That, and the tremendous belief of the American public in
the omnipotence of science and the importance of scientific achievement as
we emerge from World War II, opened the way to a new era in medical
investigation.
In 1944, the American Congress passed an act, the Public Health
Service Act, which tremendously increased the amount of money that the
taxpayer would devote to science. An associate professor from NYU,
James Shannon, was sent down to the National Institutes of Health (NIH),
which at the time consisted of four little wooden buildings in Bethesda, and
he presided in the next thirteen years over a tremendous expansion in
resources-both human and brick and mortar-at the NIH. It made the
NIH, by the mid-1960s, the foremost leader in biomedical technology and
knowledge, and started what is arguably the jewel in the crown of the
United States.
The decades that followed the war were very much colored by the
Nuremberg Trials and the discovery of the atrocities that had been
perpetrated on unwilling subjects, without their consent or knowledge. This
spawned a whole sequence of protective legislation in this country and
others, which really concentrated on the rights of the individual to
understand what research was being proposed, the risks involved, and a
development of safeguards for the subject. The Kefauver Harris
Amendments were prompted by the thalidomide disaster and it gave meat-
and-bones, so to speak, to the FDA for the first time. The Helsinki
Declaration reiterated the rights of the patient to refuse and/or participate in
clinical investigations, which sprang out of the atrocities that came out
from Nuremberg. We had the National Research Act of 1974 and finally,
and this was a turning point, the Belmont Report, which for the first time
said that if women were to benefit from the consequences of medical
investigation, that they had in justice an obligation to participate in the risk
of clinical investigation, an idea that had not really been advanced before.
So, women's health came into its own and so did women's risks.
Really, they entered a new era, from 1985 to 1999, also supported by
legislation, both at the congressional level, at the NIH, and in part from the
FDA, so that by the end of the century, we understood that women were
important to study, that they had tremendous and widespread differences
from men, and that, when we compared the data from men and women, we
formulated questions we never would otherwise have asked. This
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transformative decade at the end of the century has really been a turning
point for us. The medical investigation literature began to be apparent in
the 1990s in the cardiovascular community.
In 1988 we began a substantive movement to directly investigate
women. By 1994 and through 2000, we formulated the idea that the study
of both male and females, in spite of our wish to protect women and to
have "a standardized system," namely the male, in which to do
investigation, was flawed. We developed the notion of gender-specific
medicine all throughout this country, and Florence Haseltine is one of my
most admired forerunners of the notion that women's health is important.
She was one of the people that helped couch it in terms of the relevance to
men's health as well. The other great door that opened was the description
of the human genome in 2000, and the Encode, which is an international
society that continues to explain how complex the regulation of the genome
is and how many factors enter into it, came into being.
So where are we now in the first decade of this century? We are more
aware than we have ever been in human history of the extent and
complexity of sex and gender-specific properties of living organisms. We
are exploring, as a second point, a very interesting interface between the
environment, our genome, and the phenotype. We are what we experience,
in a very real sense, and there is no such thing as "hardwired" that's
independent of the environment in which we and all living things are
raised.
Finally, we have the latest challenge in medicine that I would like to
talk to you about: synthetic biology. There is a new age, coming or here,
headed by Craig Venter, George Church at MIT, and others. It is the age of
synthetic biology and for the first time in history, arguably, it can be said
that we have the power to generate entirely new forms of life in quite
simple ways, in many respects, which themselves may be capable of
reproductions. This is a new power that we have.
So, here are some important issues. No matter how often we ask the
question and debate it as we used to at the NIH, at the Office of Research
on Women's Health, we will never answer the question about how hard-
wired and immutable our lives are. Some people say we do not even have
free will because of our biological constitutions. What is the impact of
other factors, what can we do with training, education, social reforms, and
so on, to impact the phenotype and the way that people behave? The
second important question is, does sex matter? Can we just take a cheek
swab and send it off to someplace and find out what's going to happen to
us, what we are susceptible to? Does whether we are male or female have
an impact on the expression of our DNA? I had the enviable opportunity as
a second of a keynote address in Tel Aviv to follow a Nobel Laureate, who
said gender was out, that it did not matter anymore, that male and female
did not matter, all that we had to do was look at the genome and we get the
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answers. In fact, the same genes are expressed differently depending upon
the sex of the individual. The take-home message is that it is not possible,
in my opinion, to separate the organism from its experience, and to answer
what is sex-specific, and what is gender-specific. It is not a question
anymore, it all follows a final common path, and how we are treated has an
important consequence to what we inevitably become. And this quote is
worth reading: "[t]here is no gene-controlled inheritable trait that cannot be
altered by the environment. [ ... ] Humans enter the world as a work-in-
progress [ ... ] nature/nurture is not an either/or duality, but, rather
represents a both/and type of complementarity."' It is not a duality. So all
of you, each one of you, is what you have in your DNA, but also where you
have been, and what you have learned from the world in which you were
placed.
A new dawn certainly came to the world in 2000, when the White
House announced a completion of a rough draft of the genome, and three
years later, the Human Genome Project announced a much more complete
and accurate version. Now we understood that there was a pattern, how it
worked. Marshall Nuremberg was a great friend of mine, and the
description of how he explained the code, how he broke the code of the
human genome, was one of the most poignant and beautiful experiences
and conversations I have ever had. He was about thirty-five years old as I
recall, very young.
To say that the genome is the Rosetta Stone for disease, and that we
can take your DNA and tell you what is going to happen to you, is absurd
because it ignores the impact of the things I have been talking about: the
physical, chemical, and environmental factors. We don't want to be
reductionist or simplistic. As I have said in fifty ways up until now, the
whole regulation of how your genes are expressed is incredibly complex,
and the complexity continues to evolve in ways that stagger my mind as I
read about it. We want to know what the organizational nature of the
whole organism is, not just its disparate parts, so we have to look at things,
as it were, in context.
Three hundred million years ago there were no males and females and
then there was a mutation on one of the X-chromosomes that made it an
isolationist gene in a way, which I like to think tells us something about
men and their nature. The chromosome could not combine any longer with
X, look to it for repairs or exchanges along most of its length. And it also
became the determinate of male sex. That's how we got it, but the
important questions are how do the sexes differ, which is heartier and in
1. LEONARD SHLAIN, SEX, TIME AND POWER: How WOMEN'S SEXUALITY SHAPED
HUMAN EVOLUTION xvi (2003).
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what respect, and how is the prevention and cure of disease different as a
function of whether our patient is male or female.
Now, maleness and femaleness is not just a question of gonadal
hormones. How many of you have heard of this remarkable bird that is
half male and half female? This bird alighted in the prepared environment
of an investigator, and the bird had a testicle, a testes, on one side of its
body, male plumage, and a male configuration to its brain. And on the
other side, an ovary, a female brain, and female plumage. So here was this
hermaphroditic organism that appeared quite frequently actually in nature,
bathed by the same hormones, but clearly had a sexually dimorphic brain.
The song that was generated depended upon the abilities of the male brain
to generate the characteristic mating call of the finch; the female part of the
brain was unable to do this. I found that really fascinating, but it was, in
fact, this model, a natural proof that hormones don't determine our destiny
either.
There was a spectacular paper by Yang's group, from California, which
showed that thousands of genes are expressed differently in at least four
tissues of the body depending on whether the owner of that same gene is
male or female.2 That's amazing, we had no idea. As Yang's group said,
"We saw striking and measurable differences in more than half of the
genes' expression patterns between males and females. We didn't expect
that."3 Echoing the words of the Institute of Medicine's first monograph on
sex, entitled in part "Does Sex Matter?," the editor wrote, "Sex does
matter. It matters in ways that we did not expect. Undoubtedly, it also
matters in ways that we have not begun to imagine."A
So this has all come as a great surprise. Sex is important. Men and
women are different. We are all products, in part, of our biologic wiring if
you will, but also, importantly, as a result of how we are treated and
trained.
Is manipulating the genome, which we are clearly doing, and certainly
more and more extensively planning to do, interfering with evolution, or by
definition, is it a continuation of evolution and our capacities to overcome
challenge and change the world in which we live? Scientists are taking
genes out and inserting others. They are creating biologic specimens
capable of reproduction. And they are giving us an increasingly precise
2. See Xia Yang et al., Tissue-Specific Expression and Regulation of Sexually
Dimorphic Genes in Mice, 16 GENOME RES. 995 (2006).
3. News Release, Elaine Schmidt, Health Sciences Media Relations, UCLA, UCLA
Study Finds Same Genes Act Differently in Males and Females; Discovery May Explain
Gender Gap in Disease Risk, Drug Response (July 7, 2006), available at
http://newsroom.ucla.edu/portal/ucla/PRN-UCLA-Study-Finds-Same-Genes-Act-7177.aspx.
4. COMM. ON UNDERSTANDING THE BIOLOGY OF SEX AND GENDER DIFFERENCES, INST.
MED., EXPLORING THE BIOLOGICAL CONTRIBUTIONS TO HUMAN HEALTH: DOES SEX MATTER?
x (Theresa M. Wizemann and Mary-Lou Pardue eds., 2001).
[Vol. 23:168 HASTINGS WOMEN'S LAW JOURNAL
picture of who we are, and the possibility of changing who we are, in
profound and new ways at a molecular level. It's my hypothesis that
evolution is no longer natural selection as the Darwinian school ultimately
pronounced it. With the advent of genetic engineering, we can and are
changing the very nature of created life. And that's not an exaggeration.
And it's only really been possible for the last decade. It's a new time in our
history. Imagine these things: human cloning, engineering the
characteristics of new humans being prepared, as DARPA is trying to do,
for specific functions like war, where pain or the awareness of pain is
muted, where bleeding can be stopped virtually instantly by an individual.
We are learning to prolong the lifespan more and more, perhaps some
people think indefinitely. We are creating new biological systems capable
of reproduction and, if this is so, also capable themselves of evolution.
So these questions come up now, which of course wouldn't have been
imagined when I was even an associate professor, much less a medical
student. Will it be an advantage as we create these new life forms to retain
two sexes? Interesting question. If we eliminate biological sex in our new
forms of life before we understand the nature and extent of biological sex
expression on genes, what will be the consequence to form and function of
the finished product? We don't know. So does the study of the impact of
sex, biological sex, on gene expression deserve more attention? And if you
read the genomic literature, there is very little reference to male or female.
It's just a paean, if you will, of praise and interest in the molecular biology
of genetics, but it does not take gender or sex at all, that I have seen in any
case.
What scientists should be, and are, worrying about is: the economics of
what we're doing, the nature, and number of living beings, and the
redistribution of power as a result of what we are doing, both planned and
unplanned. We are changing the rate and mechanisms of evolution of
living things profoundly. If there is a choice between preserving the earth
in a viable state, or continuing the human race, we will probably opt to
continue the race. This quote, I think, is very good: "[I]f the molecular,
cellular, and genetic machinery used to conceive, develop, and operate a
human were designed rather than the result of evolution, humans would be
different and life would look different."
Now we have this new discipline of synthetic biology, which is the
ability to create living organisms from inert chemicals. Venter's group in
May 2010 reported the design, synthesis and assembly of a genome from
inert chemicals and its transplantation into a recipient's cell to create new
5. S. Jay Olshansky et al., What if Humans Were Designed To Last?, THE SCIENTIST,
March 1, 2007, at 28.
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cells which were controlled only by the synthetic chromosome.6 This
brought forth, as you can imagine, a whole welter of opinions. President
Obama, predictably, formed a counsel, a Commission for the Study of
Bioethical Issues, to focus on this kind of research. George Church said, in
effect, that this was not so wonderful an achievement as advertised. As he
said, "printing out a copy of an ancient text is not the same as
understanding the language." 7  So he is an archconservative. But there
were theologians and ethicists who said that this challenged our very
concept of whether or not life had a spiritual side at all, and in some
instances, whether God existed, and whether man had free will.
We are at a different time, I must say, in science. Sir John Maddox, the
former editor of Nature, said:
My guess is that if the question of human extinction is ever posed
clearly, people will say that it's all very well to say we've been a
part of nature up until now, but at this turning point in the human
race's history, it is surely essential that we do something about it;
that we fix the genome, to get rid of the disease that's causing the
instability, if necessary we clone people known to be free of risk
because that's the only way in which we can keep the human race
alive. A still, small voice may at that stage ask what right does the
human race have to claim precedence for itself. To which my
guess is the full-throated answer would be, sorry, the human race
has taken a decision, and that decision is to survive. And, if you
like, the hell with the rest of the ecosystem.
That's a provocative and interesting comment. Another pair of experts
say this: "Given the momentum and the international character of research
in synthetic biology, it is already too late to impose a moratorium, if indeed
one were ever contemplated." 9 I'm reminded of the legend of Prometheus
who gave men fire and the gods, as you know, chained him to a rock. His
liver was eaten out by raven in punishment, restored at night and he was
exposed to the same ordeal the next day. So we are, perhaps, a little like
Prometheus.
I think we should be focusing a gender specific lens on men. It's all
been about women's health and our excitement about this, we've sort of
caught up on that both emotionally and intellectually. We have to continue
6. Daniel G. Gibson et al., Creation of a Bacterial Cell Controlled by a Chemically
Synthesized Genome, SCIENCE, July 2010, at 52.
7. George Church, Opinion, Life After the Synthetic Cell: Now Let's Lower Costs, 465
NATURE 422, 422 (2010).
8. Complexity and Catastrophe: A Talk with Sir John Maddox, EDGE,
http://edge.org/conversation/complexity-and-catastrophe (last visited Oct. 26, 2011).
9. Jonathan B. Tucker & Raymond A. Zilinskas, The Promise and Perils of Synthetic
Biology, NEW ATLANTIS: J. TECH. & Soc'v, Spring 2006, at 25, 44.
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of course to pursue information about women but we should also focus that
same kind of gender-specific lens on men. Why do men die first? Why
does coronary disease have its symptoms in the thirties in many men, and
why do men with established coronary disease usually die at or about the
age of sixty-five? That's just not acceptable. I think instead of going red
for women we should also go blue for men in the American Heart
Association. And look at some of these sex-specific vulnerabilities of
males, who have been so generous, I have to say, in agreeing to be the
exclusive subjects of our research for these many decades. I think it's
extremely important. Florence Haseltine and I both testified at the Institute
of Medicine to this expert committee who said, "Is gender-specific
medicine important?" I said then, and I'm saying again: it remains to be
seen whether or not what we are finding out about the sex-specific unique
characteristics of each gender, when applied, actually improve survival and
help us prevent and cure disease. We have been generating a tremendous
amount of information, and it is now important to translate that into
whether or not in fact it does help protect and preserve human life.
On a final note, one reason why I agreed to come to this meeting is
because I have long wanted to have a colloquium between jurists, lawyers,
theologians, anthropologists, historians, and scientists about the legal and
moral implications of the new science, both of genomic science and, more
specifically, of synthetic biology. So thank you for inviting me, it has been
a wonderful morning, and I'm sure the afternoon will be just as rich.
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